Sfoglia per Autore
Slow evolution of liver metastasis from colon cancer
2005 G. Biasco, M. Di Battista, E. Derenzini
Treatment of hepatic metastases from colorectal cancer: Many doubts, some certainties
2006 G. Biasco, E. Derenzini, G. Grazi, G. Ercolani, M. Ravaioli, M.A. Pantaleo, G. Brandi
Treatment of colorectal cancer liver metastases
2006 E. Derenzini, M. Di Battista, M.C. Di Marco, S. Dell'Arte, M. Astorino, S. Bertolini, G. Brandi, G. Biasco
VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly
2007 M. Fina, M. Tani, V. Stefoni, G. Musuraca, E. Marchi, C. Pellegrini, L. Alinari, E. Derenzini, F. Bacci, S. Pileri, M. Baccarani, P.L. Zinzani
Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma
2007 P.L. Zinzani, G. Musuraca, M. Toni, V. Stefoni, E. Marchi, M. Fina, C. Pellegrini, L. Alinari, E. Derenzini, A. De Vivo, E. Sabattini, S. Pileri, M. Baccarani
Bronchus-associated lymphoid tissue lymphomas : an update of a rare extranodal maltoma
2007 P.L. Zinzani, V. Poletti, M. Zompatori, M. Tani, L. Spaggiari, S. Tomassetti, A. Broccoli, E. Derenzini, M. Baccarani
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ)
2008 P.L. Zinzani, M. Tani, A. Pulsoni, M. Gobbi, A. Perotti, S. De Luca, A. Fabbri, A. Zaccaria, M.T. Voso, P. Fattori, L. Guardigni, S. Ronconi, M.G. Cabras, L. Rigacci, A. De Renzo, E. Marchi, V. Stefoni, M. Fina, C. Pellegrini, G. Musuraca, E. Derenzini, S. Pileri, S. Fanti, P.P. Piccaluga, M. Baccarani
Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: A diagnostic and therapeutic challenge
2008 E. Derenzini, S. Paolini, G. Martinelli, C. Campidelli, G.L. Grazi, C. Calabrese, P.L. Zinzani, M. Baccarani
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma
2008 E. Derenzini, G. Musuraca, S. Fanti, V. Stefoni, M. Tani, L. Alinari, F. Venturini, L. Gandolfi, M. Baccarani, P.L. Zinzani
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients
2008 P.L. Zinzani, M. Tani, S. Fanti, V. Stefoni, G. Musuraca, P. Castellucci, E. Marchi, M. Farsad, M. Fina, C. Pellegrini, L. Alinari, E. Derenzini, A. de Vivo, F. Bacci, S. Pileri, M. Baccarani
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma
2008 P.L. Zinzani, M. Tani, S. Fanti, V. Stefoni, G. Musuraca, U. Vitolo, A. Perrotti, M. Fina, E. Derenzini, M. Baccarani
Gemcitabine
2009 M. Tani, L. Alinari, A. Broccoli, E. Derenzini, M. Fina, L. Gandolfi, E. Marchi, C. Pellegrini, V. Stefoni, F. Venturini, P.L. Zinzani
CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission
2009 V. Stefoni, A. Broccoli, C. Pellegrini, E. Derenzini, M. Fina, P.L. Zinzani
Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma
2009 P.L. Zinzani, V. Stefoni, M. Tani, S. Fanti, G. Musuraca, P. Castellucci, E. Marchi, M. Fina, V. Ambrosini, C. Pellegrini, L. Alinari, E. Derenzini, G. Montini, A. Broccoli, F. Bacci, S. Pileri, M. Baccarani
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma
2009 E. Derenzini, V. Stefoni, C. Pellegrini, M.P. Fina, A. Broccoli, F. Venturini, L. Gandolfi, S.A. Pileri, M. Martelli, M.C. Petti, A. Perrotti, A. De Renzo, F. Zaja, M. Baccarani, P.L. Zinzani
Association of essential thrombocythemia and non-Hodgkin lymphoma: A single-centre experience
2009 F. Palandri, E. Derenzini, E. Ottaviani, N. Polverelli, L. Catani, F. Salmi, E. Sabattini, F. Bacci, P.L. Zinzani, M. Baccarani, N. Vianelli
Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia
2009 C. Papayannidis, E. Derenzini, I. Iacobucci, A. Curti, S. Paolini, D. Cilloni, M. Baccarani, G. Martinelli
Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: Evaluation of the long-term outcome
2010 P.L. Zinzani, L. Gandolfi, V. Stefoni, S. Fanti, M. Fina, C. Pellegrini, G.C. Montini, E. Derenzini, A. Broccoli, L. Argnani, S. Pileri, M. Baccarani
FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: Multicentric study
2010 E. Lopci, I. Santi, E. Derenzini, C. Fonti, G. Savelli, F. Bertagna, M. Bello, B. Botto, D. Huglo, F. Morschhauser, P. Zinzani, S. Fanti
Phase II trial of short-course R-Chop followed by 90Y- ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients
2010 P.L. Zinzani, G. Rossi, S. Franceschetti, B. Botto, A. Di Rocco, M.G. Cabras, M.C. Petti, V. Stefoni, A. Broccoli, S. Fanti, C. Pellegrini, G.C. Montini, L. Gandolfi, E. Derenzini, L. Argnani, M. Fina, A. Tucci, C. Bottelli, S. Pileri, M. Baccarani
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile